Opko Health Correlations

OPK Stock  USD 1.26  0.02  1.56%   
The current 90-days correlation between Opko Health and Sana Biotechnology is 0.16 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Opko Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Opko Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Opko Health Correlation With Market

Good diversification

The correlation between Opko Health and DJI is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Opko Health and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Moving together with Opko Stock

  0.64EDIT Editas MedicinePairCorr
  0.71AIM AIM ImmunoTechPairCorr
  0.63XBIO Xenetic BiosciencesPairCorr
  0.62JSPR Jasper TherapeuticsPairCorr

Moving against Opko Stock

  0.45GILD Gilead Sciences Earnings Call This WeekPairCorr
  0.44VYNE Vyne TherapeuticsPairCorr
  0.32VRTX Vertex Pharmaceuticals Earnings Call TomorrowPairCorr
  0.41REGN Regeneron PharmaceuticalsPairCorr
  0.36ADAG AdagenePairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LFMDCTEV
NKTRCTEV
DNTHOCS
NKTRXNCR
PCRXXNCR
PCRXTNDM
  

High negative correlations

LFMDTNDM
DNTHLFMD
NKTROCS
TNDMCTEV
DNTHCTEV
OCSXNCR

Risk-Adjusted Indicators

There is a big difference between Opko Stock performing well and Opko Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Opko Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SANA  4.27 (0.29) 0.00 (0.05) 0.00 
 12.59 
 25.63 
CTEV  5.00 (1.14) 0.00  0.79  0.00 
 10.44 
 36.36 
XNCR  2.77 (0.22) 0.00  0.47  0.00 
 6.33 
 16.84 
OCS  1.89  0.50  0.19  1.58  1.86 
 5.79 
 15.08 
PSNL  4.51 (0.03) 0.02  0.04  4.96 
 14.09 
 34.91 
NKTR  3.70 (0.65) 0.00 (0.84) 0.00 
 6.56 
 20.31 
TNDM  2.91  0.48  0.14  0.66  2.98 
 7.03 
 27.14 
LFMD  3.44 (0.98) 0.00 (0.27) 0.00 
 8.13 
 28.11 
DNTH  2.74  0.81  0.25 (1.19) 2.25 
 8.00 
 22.10 
PCRX  2.14 (0.07) 0.00 (0.03) 0.00 
 4.50 
 14.20 

Opko Health Corporate Executives

Elected by the shareholders, the Opko Health's board of directors comprises two types of representatives: Opko Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opko. The board's role is to monitor Opko Health's management team and ensure that shareholders' interests are well served. Opko Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opko Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Adam LogalCFO, Chief Accounting Officer, Sr. VP and TreasurerProfile